Emerging pharmacological strategies for the treatment of fibromyalgia

LAWSON, Kim (2017). Emerging pharmacological strategies for the treatment of fibromyalgia. World Journal of Pharmacology, 6 (1), 1-10.

Lawson_WJP_2017-6-1.pdf - Published Version
Creative Commons Attribution Non-commercial.

Download (877kB) | Preview
Official URL: http://www.wjgnet.com/2220-3192/full/v6/i1/1.htm
Link to published version:: https://doi.org/10.5497/wjp.v6.i1.1


Fibromyalgia (FM) has been described as a chronic clinical condition related to multisensory hypersensitivity presenting with a complex of symptoms dominated by chronic widespread pain associated with the existence of a range of co-morbidities, such as fatigue, sleep disturbance, cognitive impairment, anxiety and depression. Current treatments include drugs that target serotonin and noradrenaline levels within the central nervous system, e.g. , tricyclic antidepressants, serotonin noradrenaline reuptake inhibitors, and voltage-gated calcium channel subunit ligands, e.g. , gabapentin and pregabalin. Investigation of a range of novel targets, such as melatoninergic, cannabinoid, dopamine, NMDA, angiotensin, orexin and opioid receptors, and ion channels, in addition revisiting bioamine modulation and subunits has provided efficacy outcomes that improve the health status of patients with FM. Nevertheless, modest and limited efficacy is often observed reflecting the heterogeneity of FM with existence of subpopulations of patients, the contribution of peripheral and central components to the pathophysiology, and the extensive range of accompanying co-morbidities. The complexity and multidimensional nature of FM is emphasized by the diversity of pharmacological targets gaining interest. Clues to underlying mechanisms which offer themselves as novel and potential targets for new medications are being provided by advances in the understanding of the pathophysiology of FM.

Item Type: Article
Research Institute, Centre or Group - Does NOT include content added after October 2018: Biomedical Research Centre
Departments - Does NOT include content added after October 2018: Health and Well-being > Department of Bioscience
Identification Number: https://doi.org/10.5497/wjp.v6.i1.1
Page Range: 1-10
Depositing User: Kim Lawson
Date Deposited: 09 Mar 2017 15:37
Last Modified: 18 Mar 2021 16:21
URI: https://shura.shu.ac.uk/id/eprint/15300

Actions (login required)

View Item View Item


Downloads per month over past year

View more statistics